50 results on '"Magrini, Umberto"'
Search Results
2. Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease
3. Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation
4. Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype.
5. Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm.
6. Nijmegen Breakage Syndrome-associated T-cell-rich B-cell Lymphoma: Case Report
7. Unique vascular tumor primary arising in the liver and exhibiting histopathological features consistent with so-called polymorphous hemangioendothelioma
8. Aberrant phenotype of plasmacytoid monocytes in acute myeloid leukemia
9. Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations
10. Dyspnea Secondary to Pulmonary Hematopoiesis as Presenting Symptom of Myelofibrosis With Myeloid Metaplasia
11. EBV Positive Primary Cutaneous CD30+ Large T-Cell Lymphoma in a Heart Transplanted Patient: Case Report
12. Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency
13. Molecular histogenesis of posttransplantation lymphoproliferative disorders
14. Genetics, clinical and pathological features of glomerulonephrites associated with mutations of nonmuscle myosin IIA (Fechtner syndrome)
15. A low serum β2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implications for serologic staging
16. Deregulated Genes in Hematopoietic Stem Cells Isolated from Spleen of Patients with Myelofibrosis
17. Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.
18. V617FJAK2-Positive Endothelial Cells Are Present in Bone Marrow Neovessels of Patients with Myelofibrosis and Could Derive from the Transdifferentiation of Mutated Hematopoietic Cells
19. Somatic and Germ-Line Molecular Characteristics Of Prefibrotic Myelofibrosis
20. Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome.
21. Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis.
22. High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein Thrombosis.
23. Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis.
24. B-cell Posttransplant Lymphoproliferative Disorders in Heart and/or Lungs Recipients: Clinical and Molecular-Histogenetic Study of 17 Cases from a Single Institution.
25. research paper Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency.
26. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.
27. Prefibrotic Myelofibrosis (PreMF) Belongs to a Continuum of Epidemiological, Clinical and Histological Characteristics Featuring Primary Myelofibrosis (PMF)
28. Does auto-immunity contribute to anemia in myeloproliferative neoplasms (MPN)-associated myelofibrosis?
29. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases.
30. An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression.
31. Red cell aplasia in myelofibrosis with myeloid metaplasia. A distinct functional and clinical entity.
32. An Enzyme-Histochemical Approach to the Study of the Human Bone-Marrow Stroma.
33. Bone marrow and blood involvement by non-Hodgkin's lymphoma: A study of clinicopathologic correlations and prognostic significance in relationship to the Working Formulation.
34. Pulmonary Arteriovenous Fistulas.
35. Nodular Lymphocyte Predominance Hodgkin's Disease: Long-Term Observation Reveals a Continuous Pattern of Recurrence.
36. Incidence and Clinical Profile of JAK2 V617F Mutation in Myelofibrosis with Myeloid Metaplasia.
37. Angiosarcoma of the heart: Report of a case in a 9-year-old boy.
38. Aberrant phenotype of plasmacytoid monocytesin acute myeloid leukemia.
39. The Role of Human Herpesvirus 8 and Epstein-Barr Virus in the Pathogenesis of Giant Lymph Node Hyperplasia (Castleman's Disease).
40. Ploidy and proliferative activity measurement by flow cytometry in non-hodgkin's lymphomas. Do speculative aspects prevail over clinical ones?
41. ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum
42. Thrombocytopenia, Giant Platelets, and Leukocyte Inclusion Bodies (May-Hegglin Anomaly): Clinical and Laboratory Findings
43. CONGENITAL HEPATIC FIBROSIS
44. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
45. Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia.
46. Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis.
47. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
48. Eber- and LMP-1-expressing pulmonary lymphoepithelioma-like carcinoma in a Caucasian patient.
49. Marginal zone-related neoplasms of splenic and nodal origin.
50. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.